Professor Tony Blakely
Head of Population Interventions Unit, Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne
See research profile
Business & Economics
Vaping is ‘a young person phenomenon’ in Australia
For the first time, the annual HILDA survey has explored who is using vapes and e-cigarettes. And it’s Australia’s young people getting hooked
Health & Medicine
The steps we can take to combat COVID-19 in 2023
New computer modelling suggests that ongoing vaccinations and early public health measures are the most effective responses to future COVID-19 variants
Health & Medicine
NSW should be ‘okay’ opening up
New modelling suggests that NSW – as well Victoria and ACT – should have confidence that opening up will be ‘okay’ at 70 to 80 per cent double vaccinated
Health & Medicine
What if Victoria cannot eliminate Delta this time?
If the current hard lockdown in Victoria doesn’t see a dramatic reduction in COVID-19 cases by 2 September, what are the options on the table?
Health & Medicine
The strength of Sydney’s lockdown is crucial over the next 100 days
Speeding up the vaccine rollout in Sydney and New South Wales helps with the Delta outbreak, but lockdowns may matter more in the short term
Health & Medicine
We need to talk about elimination vs suppression in Australia again
New epidemiological and economic modelling finds that elimination is better than a suppression strategy for COVID-19
Health & Medicine
Australia needs a more rational, evidence-based border policy
Arbitrary caps on numbers and mandatory hotel quarantine for even very low-risk international arrivals is irrational and costly. And a lost opportunity
Health & Medicine
How long till Sydney gets out of lockdown?
New COVID-19 modelling finds NSW’s hard decision to go into hard lockdown gives the State more certainty about how long they’ll be stuck in there
Health & Medicine
What’s the right COVID-19 risk to live with?
As Australia looks toward opening its international borders, new virus modelling provides scenarios that can help us decide what’s the right risk to tolerate